Hos GIST- patienter var optagelsen ved steady- state 1, 5 gange højere end den observeret hos CML - patienter ved samme dosis (400 mg daglig).
Pharmacokinetics in GIST patients In patients with GIST steady-state exposure was 1.5-fold higher than that observed for CML patients for the same dosage (400 mg daily).